In accordance with the Rules and Procedures of the 2010–2015 Council of Experts, the Monographs—Small Molecules 3 Expert Committee has revised the Glimepiride Tablets monograph. The purpose for the revision is to include Dissolution Tests 2 and 3 for generic products approved by the FDA.
The Glimepiride Tablets Revision Bulletin supersedes the currently official Glimepiride Tablets monograph. The Revision Bulletin will be incorporated in the Second Supplement to USP 34–NF 29.
Should you have any questions, please contact Margareth Marques, Ph.D. (301-816-8106 or MRM@usp.org).